phospholipid/hemorrhage

BACKGROUND OF THE INVENTION (1) Field of the Invention The present invention relates to factor X zymogen compositions useful for inducing hemostasis. The compositions are generally substantially free of activators for the X zymogen. (2) Prior Art Clinical treatment of bleeding disorders arising from

FIELD OF THE INVENTION The present invention generally relates to manipulation of blood coagulation. More particularly the invention relates to compositions for altering bleeding that include at least one blood coagulation factor and phospholipid vesicles. The invention has a variety of important

The present invention relates to a pharmaceutical composition for preventing or treating a hemorrhagic accident in a patient with hemophilia A or B by means of a modified factor X. Hemophilia A, like hemophilia B, includes two types of hemophilia, constitutional hemophilia and acquired

REFERENCE TO A SEQUENCE LISTING SUBMITTED ELECTRONICALLY The content of the electronically submitted sequence listing (Name: 2159_3840001_SequenceListing.txt; Size: 112,914 bytes; and Date of Creation: Jan. 16, 2015) is herein incorporated by reference in its entirety. BACKGROUND Field of the

INTRODUCTION Bone is highly vascularized and, when cut, can bleed profusely. Bleeding can be difficult to control during orthopedic surgeries, particularly involving the spine and sternum. Moreover, techniques such as cauterization that can be used to control bleeding in soft tissue are not